10-Jan-2026 6:14 AM CST - Seeking Alpha Innodata: Progress Is Real, Upside Priced In Innodata remains a hold with rich valuation, $247M 2025 revenue, $350M 2026 outlook, new contracts, and AI-driven volatility. See why INOD stock is a hold.
30-Jul-2025 3:50 AM CST - The Motley Fool Is Iovance Biotherapeutics Stock Due for a Big Rally? Shares of Iovance Biotherapeutics ( IOVA -1.02%) have been in a free fall this past year, but in recent weeks, they have experienced a bit of a surge in value. The volatile biotech stock has been picking up steam, and the share price is up roughly 67% in just the past month.
10-Jan-2026 6:14 AM CST - Seeking Alpha Innodata: Progress Is Real, Upside Priced In Innodata remains a hold with rich valuation, $247M 2025 revenue, $350M 2026 outlook, new contracts, and AI-driven volatility. See why INOD stock is a hold.
30-Jul-2025 3:50 AM CST - The Motley Fool Is Iovance Biotherapeutics Stock Due for a Big Rally? Shares of Iovance Biotherapeutics ( IOVA -1.02%) have been in a free fall this past year, but in recent weeks, they have experienced a bit of a surge in value. The volatile biotech stock has been picking up steam, and the share price is up roughly 67% in just the past month.
